1. Home
  2. CECO vs HRMY Comparison

CECO vs HRMY Comparison

Compare CECO & HRMY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo CECO Environmental Corp.

CECO

CECO Environmental Corp.

HOLD

Current Price

$52.40

Market Cap

1.9B

Sector

Industrials

ML Signal

HOLD

Logo Harmony Biosciences Holdings Inc.

HRMY

Harmony Biosciences Holdings Inc.

HOLD

Current Price

$28.39

Market Cap

1.7B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CECO
HRMY
Founded
1966
2017
Country
United States
United States
Employees
N/A
N/A
Industry
Pollution Control Equipment
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.9B
1.7B
IPO Year
2002
2020

Fundamental Metrics

Financial Performance
Metric
CECO
HRMY
Price
$52.40
$28.39
Analyst Decision
Strong Buy
Buy
Analyst Count
4
10
Target Price
$77.75
$46.70
AVG Volume (30 Days)
657.7K
1.1M
Earning Date
01-01-0001
05-18-2026
Dividend Yield
N/A
N/A
EPS Growth
280.56
7.97
EPS
1.37
2.71
Revenue
N/A
$868,453,000.00
Revenue This Year
$24.84
$19.87
Revenue Next Year
$11.51
$12.49
P/E Ratio
$39.64
$10.46
Revenue Growth
N/A
21.51
52 Week Low
$17.57
$25.52
52 Week High
$81.72
$40.87

Technical Indicators

Market Signals
Indicator
CECO
HRMY
Relative Strength Index (RSI) 29.67 31.77
Support Level $44.68 $26.36
Resistance Level $53.73 $37.38
Average True Range (ATR) 4.11 1.82
MACD -2.50 -0.21
Stochastic Oscillator 1.78 21.42

Price Performance

Historical Comparison
CECO
HRMY

About CECO CECO Environmental Corp.

CECO Environmental Corp serves the energy, industrial, and other niche markets. The company operates through the Engineered Systems segment that serves the power generation, refinery, water/wastewater, and midstream oil and gas markets, and Industrial Process Solutions segment, which serves the broad industrial air pollution control, beverage can, fluid handling, electric vehicle production, food and beverage, semi-conductor, process filtration, pharmaceutical, petrochemical, wastewater treatment, wood manufacturing, desalination, and aquaculture markets. The majority of revenue is earned from the Engineered Systems Segment.

About HRMY Harmony Biosciences Holdings Inc.

Harmony Biosciences Holdings Inc is a commercial-stage pharmaceutical company focused on developing and commercializing therapies for patients living with rare neurological diseases who have unmet medical needs. The company has one reportable segment: rare neurological diseases. Its product WAKIX (pitolisant) is a molecule with a novel mechanism of action specifically designed to increase histamine signaling in the brain by binding to H3 receptors and is used for the treatment of cataplexy in adult patients with narcolepsy. The other drug candidates in its pipeline are Pitolisant, HBS-102 (MCHR1 antagonist), BP1.15205 (orexin-2 receptor agonist), ZYN002 (cannabidiol gel), EPX-100 (clemizole hydrochloride), and EPX-200 (lorcaserin), among others.

Share on Social Networks: